- Published at
- by seekingalpha.com
positive
positive
West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST)
West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.